中华物理医学与康复杂志
中華物理醫學與康複雜誌
중화물리의학여강복잡지
CHINESE JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION
2009年
11期
763-766
,共4页
何明利%王新一%徐丙超%李在坡%蒋海华
何明利%王新一%徐丙超%李在坡%蔣海華
하명리%왕신일%서병초%리재파%장해화
重复经颅磁刺激%失眠症%疗效
重複經顱磁刺激%失眠癥%療效
중복경로자자격%실면증%료효
Transcranial magnetic stimulation%Insomnia
目的 对比研究睡眠脑中波调制重复经颅磁刺激(SEM-rTMS)与常规重复经颅磁刺激(常规rTMS)对原发性失眠的临床疗效和安全性.方法 选择126例原发性失眠患者,随机分为SEM-rTMS组44例、常规rTMS组42例和假rTMS组40例,在患者和治疗师双盲前提下,每次治疗30 min,每日1次,疗程为10 d,分别观察3组治疗前、治疗第10天(全程治疗结束时)和治疗结束后30 d的临床疗效、Krakow睡眠积分、脑电图和平均血压的变化.结果 磁疗中,部分患者有浅睡感.其脑电图同步出现睡眠脑中波,以SEM-rTMS组更明显.治疗结束时,SEM-rTMS组和常规rTMS组的有效率分别为79.55%和45.24%,前者显著高于后者(P<0.001).治疗结束后30 d,SEM-rTMS组的有效率仍显著高于常规rTMS组(P<0.05).3组在观察期间未发现明显副作用.结论 SEM-rTMS治疗原发性失眠的疗效显著、稳定、安全,显著优于常规rTMS.
目的 對比研究睡眠腦中波調製重複經顱磁刺激(SEM-rTMS)與常規重複經顱磁刺激(常規rTMS)對原髮性失眠的臨床療效和安全性.方法 選擇126例原髮性失眠患者,隨機分為SEM-rTMS組44例、常規rTMS組42例和假rTMS組40例,在患者和治療師雙盲前提下,每次治療30 min,每日1次,療程為10 d,分彆觀察3組治療前、治療第10天(全程治療結束時)和治療結束後30 d的臨床療效、Krakow睡眠積分、腦電圖和平均血壓的變化.結果 磁療中,部分患者有淺睡感.其腦電圖同步齣現睡眠腦中波,以SEM-rTMS組更明顯.治療結束時,SEM-rTMS組和常規rTMS組的有效率分彆為79.55%和45.24%,前者顯著高于後者(P<0.001).治療結束後30 d,SEM-rTMS組的有效率仍顯著高于常規rTMS組(P<0.05).3組在觀察期間未髮現明顯副作用.結論 SEM-rTMS治療原髮性失眠的療效顯著、穩定、安全,顯著優于常規rTMS.
목적 대비연구수면뇌중파조제중복경로자자격(SEM-rTMS)여상규중복경로자자격(상규rTMS)대원발성실면적림상료효화안전성.방법 선택126례원발성실면환자,수궤분위SEM-rTMS조44례、상규rTMS조42례화가rTMS조40례,재환자화치료사쌍맹전제하,매차치료30 min,매일1차,료정위10 d,분별관찰3조치료전、치료제10천(전정치료결속시)화치료결속후30 d적림상료효、Krakow수면적분、뇌전도화평균혈압적변화.결과 자료중,부분환자유천수감.기뇌전도동보출현수면뇌중파,이SEM-rTMS조경명현.치료결속시,SEM-rTMS조화상규rTMS조적유효솔분별위79.55%화45.24%,전자현저고우후자(P<0.001).치료결속후30 d,SEM-rTMS조적유효솔잉현저고우상규rTMS조(P<0.05).3조재관찰기간미발현명현부작용.결론 SEM-rTMS치료원발성실면적료효현저、은정、안전,현저우우상규rTMS.
Objective To compare sleep electroencephalogram-modulated repetitive transcranial magnetic stimulation (SEM-rTMS) with routine repetitive transcranial magnetic stimulation (R-rTMS) in the treatment of primary insomnia. Methods One hundred and twenty six patients with insomnia were divided randomly into a SEM-rTMS group (44 cases) , a R-rTMS group (42 cases) and a sham rTMS group (40 cases). Each case was treated with rTMS for 30 min once a day for 10 d under double blinding of the patient and therapist. The clinical effect was observed along with Krakow sleep scores, electroencephalograms and blood pressure before and after a 10-day course of therapy and 30 days later. Results During rTMS treatment, some patients reported feeling sleepy, and this was confirmed by their EEGs at the time. After the entire course of therapy, 80% of the SEM-rTMS group and 45% of the R-rTMS group showed improvements, a significant difference. At the 30th day after therapy, the effect in the SEM-rTMS group was still significantly better than in the R-rTMS group. There were no obvious side effects in any group throughout the whole observation period. Conclusions SEM-rTMS is more effective and more reliable than R-rTMS. SEM-rTMS is safe to use with primary insomnia patients.